Why the stock moved Salesforce Target price 2026 - Analyst rating & recommendation
Salesforce Classifications & Recommendation
Salesforce Price Target
| Target Price | $295.80 |
| Price | $250.29 |
| Potential | 18.18% |
| Number of Estimates | 53 |
| 53 Analysts have issued a price target Salesforce 2027 . The average Salesforce target price is $295.80. This is 18.18% higher than the current stock price. The highest price target is $498.75 99.27% , the lowest is $161.60 35.43% . | |
| A rating was issued by 59 analysts: 44 Analysts recommend Salesforce to buy, 13 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2027 of 18.18% . Most analysts recommend the Salesforce stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2031
53 Analysts have issued a sales forecast Salesforce 2027 . The average Salesforce sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
25 Analysts have issued an Salesforce EBITDA forecast 2027. The average Salesforce EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
55 Salesforce Analysts have issued a net profit forecast 2027. The average Salesforce net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031
Current Salesforce Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B of A Securities |
Underperform
➜
Buy
|
Upgrade | Oct 12 2026 |
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Sep 18 2026 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Sep 17 2026 |
| Freedom Broker |
Buy
➜
Buy
|
Unchanged | Sep 17 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Sep 17 2026 |
| Analyst Rating | Date |
|---|---|
|
Upgrade
B of A Securities:
Underperform
➜
Buy
|
Oct 12 2026 |
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Sep 18 2026 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Sep 17 2026 |
|
Unchanged
Freedom Broker:
Buy
➜
Buy
|
Sep 17 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Sep 17 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
